ビーエムジー Official site

3D printing filament "BioDegmer Filament"

To shorten the development and prototyping period. Active in a wide range of applications such as implants and scaffolds.

"BioDegmer Filament" is a 3D printer filament with excellent biocompatibility and biodegradability. It can be used in a wide range of applications in the medical field, such as scaffolds for implants and cell/tissue regeneration. By creating 3D models, it allows for hands-on examination of actual models, which is expected to shorten the time required for strength and precision verification, as well as testing and validation. [Features] - For research and development in the medical field - Filament diameter: 1.75mm - Consultation available for prototyping and evaluation of printed products, structural design, and 3D data creation *For more details, please refer to the materials. Feel free to contact us with any inquiries.

basic information

【Lineup (Prototype Achievements)】 - Glycolic acid / L-lactic acid copolymer (PGLA) - Poly-L-lactic acid (PLLA) - Poly-ε-caprolactone (PCL) - L-lactic acid / ε-caprolactone copolymer (LCL) - Poly-p-dioxanone (PDO)

Price range

Delivery Time

Applications/Examples of results

*For more details, please refer to the materials. Feel free to contact us as well.*

BioDegmer Filament for 3D Printers

PRODUCT

BMJ Corporation Company Profile

COMPANY

Recommended products

Distributors

BMG is a research and development venture company that has been challenging the development of new biomaterial products adapted to trends in the medical field, based on a long-standing strong collaboration with the Institute for Frontier Medical Sciences at Kyoto University. Since its founding, the company has focused on the field of medical polymers to realize its corporate philosophy of "contributing to the health of people around the world by working on the development of better medical biomaterial products and providing innovative solutions in the medical field," supporting advancements in biomaterials technology and people's health across three business areas.